Mark Berger - Feb 18, 2024 Form 4 Insider Report for Genprex, Inc. (GNPX)

Role
Chief Medical Officer
Signature
/s/ Mark Berger
Stock symbol
GNPX
Transactions as of
Feb 18, 2024
Transactions value $
-$5,804
Form type
4
Date filed
2/21/2024, 04:34 PM
Previous filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNPX Common Stock Tax liability -$5.8K -1.32K -21.53% $4.40* 4.81K Feb 18, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld on February 18, 2024 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan.
F2 This total represents the number of shares of Common Stock beneficially owned following this reported transaction and the 1-for-40 reverse stock split of the Company's Common Stock effected as of February 2, 2024.